Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 566 (LINC00566) is a long intergenic non-coding RNA gene, belonging to the family of lincRNAs. LINC00566 transcripts are RNA molecules longer than 200 nucleotides that do not code for proteins and are located in regions of the genome that do not overlap protein-coding gene sequences. LINC00566 has been associated with ovarian cancer through differential expression profiling, suggesting a potential biomarker role, but its biological functions, disease mechanisms, or suitability as a therapeutic target remain to be elucidated. No drugs are currently reported to interact with or modulate LINC00566, and its precise roles in cellular processes, epigenetic regulation, or pathogenesis are still under investigation[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 566 (LINC00566).